Stay updated on Pembrolizumab for Bladder Cancer Surgery Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Bladder Cancer Surgery Clinical Trial page.

Latest updates to the Pembrolizumab for Bladder Cancer Surgery Clinical Trial page
- Check7 days agoChange DetectedThe page now shows a new system revision label (v3.6.4), replacing the previous revision (v3.6.3), indicating a software update to the site’s interface without changing study information.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe page revision tag was updated from v3.6.2 to v3.6.3, indicating a minor version update to the page metadata.SummaryDifference0.1%

- Check35 days agoChange DetectedThe page now shows Revision: v3.6.2, replacing Revision: v3.6.0. This indicates a system update deployed to the page for maintenance or bug fixes.SummaryDifference0.1%

- Check50 days agoChange DetectedAdded a recruitment status note stating the study is no longer looking for participants. New help/navigation items were introduced, including How to Read a Study Record, Common Questions, and How to Join a Study.SummaryDifference0.5%

- Check57 days agoChange DetectedThe page's revision tag was updated from v3.5.4 to v3.5.5, signaling a new revision of the page content. This appears to be maintenance rather than a substantive change to the study information.SummaryDifference0.1%

- Check78 days agoChange DetectedThe page's revision tag is updated from v3.5.3 to v3.5.4, indicating a minor software revision for the site. This does not change the study content or layout visible to users.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab for Bladder Cancer Surgery Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Bladder Cancer Surgery Clinical Trial page.